Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.

Abstract

FAS is a reliable marker of low-stage clinically aggressive lung carcinomas. The determination of FAS expression in lung carcinomas may stratify patients and determine therapeutic approaches for their care.